Use of Anesthetic Agents: Management and New Strategy

Dear Colleagues,

The use of new anesthetic agents with the intention of promoting the recovery of patients in the postoperative process has been the subject of multiple studies. Procedures with multimodal anesthesia in which, at a pharmacological level, different approaches are addressed in the chain of nociception and in different situations of hyperalgesia, have been the subject of different research studies and meta-analyses with the intention of delving deep into the knowledge of their benefits.

On the other hand, the association of oncological recurrence with dissemination during the oncological process, thanks to the surgical procedure and possible hematogenous dissemination, and the possible regulatory role of anesthetic drugs in this type of procedure has been the subject of continuous work in which attention is drawn to the different activity of halogenated and intravenous drugs depending on the tumor type.

Finally, our knowledge of the organoprotective role of anesthetic drug administration to patients undergoing cardiac surgery or those with heart disease in the perioperative period has been advancing in recent years, drawing attention to the variation produced by these drugs in gene expression and their effect on cardiac conditioning pathways.

Therefore, we invite contributions to this Special Issue as an opportunity to evaluate anesthetic drugs as therapeutic tools.

Dr. José Luis Guerrero-Orriach
Dr. María Dolores Carmona Luque
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• anesthetic agents
• anesthetic drugs
• anesthetic
• general anesthetic agents
• therapeutic tools